Cargando…

The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial

STATEMENT OF THE PROBLEM: Periodontitis is a multifactorial disease caused by periopathogens and its severity is determined by the host immune response. Gingival crevicular fluid (GCF) can be used for non-invasive testing to assess the host response in periodontal treatment. Pentraxins are the class...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozaffari, Asieh, Samieifar, Mahtab, Abd Nikfarjam, Bahare, Mirzadeh, Monirsadat, Assareh, Shadi, Mirzapour, Samira Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719594/
https://www.ncbi.nlm.nih.gov/pubmed/36506882
http://dx.doi.org/10.30476/DENTJODS.2021.90647.1510
_version_ 1784843357472686080
author Mozaffari, Asieh
Samieifar, Mahtab
Abd Nikfarjam, Bahare
Mirzadeh, Monirsadat
Assareh, Shadi
Mirzapour, Samira Mohammad
author_facet Mozaffari, Asieh
Samieifar, Mahtab
Abd Nikfarjam, Bahare
Mirzadeh, Monirsadat
Assareh, Shadi
Mirzapour, Samira Mohammad
author_sort Mozaffari, Asieh
collection PubMed
description STATEMENT OF THE PROBLEM: Periodontitis is a multifactorial disease caused by periopathogens and its severity is determined by the host immune response. Gingival crevicular fluid (GCF) can be used for non-invasive testing to assess the host response in periodontal treatment. Pentraxins are the classic mediators of inflammation and pentraxin-3 can be used as a marker to assess response to therapy, which was investigated in this study. PURPOSE: This study aimed to assess the effect of non-surgical periodontal therapy on GCF level of pentraxin-3 in patients with chronic periodontitis. MATERIALS AND METHOD: 25 patients with chronic periodontitis (CP) and 25 periodontally healthy controls were evaluated. Pocket probing depth, clinical attachment loss, plaque index, gingival index, and bleeding on probing were measured in both groups. GCF samples were collected using paper strips to assess the level of pentraxin-3. In the CP group, GCF samples were collected from the highest clinical attachment loss, pocket probing depth, and bone loss at baseline and six weeks after non-surgical therapy. The level of pentraxin-3 in the GCF was quantified by enzyme-linked immunosorbent assay (ELISA). Data were analyzed using SPSS version 23. RESULTS: Pentraxin-3 in GCF of CP patients before treatment (6.72±4.63 ng/mL) was higher than the control group (4.43±2.85 ng/mL). Pentraxin-3 in patients after non-surgical therapy (3.2±2.66 ng/mL) decreased significantly compared to the baseline (p= 0.04) and its level after treatment was not significantly different from the control group (p= 0.14). CONCLUSION: Pentraxin-3 in GCF of CP patients was higher than healthy controls and decreased in response to non-surgical periodontal therapy. Thus, it can be used as an inflammatory marker for detection of patients at risk of CP. However, further studies with larger samples and longer follow-ups in different populations are required to confirm our findings
format Online
Article
Text
id pubmed-9719594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Shiraz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-97195942022-12-09 The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial Mozaffari, Asieh Samieifar, Mahtab Abd Nikfarjam, Bahare Mirzadeh, Monirsadat Assareh, Shadi Mirzapour, Samira Mohammad J Dent (Shiraz) Original Article STATEMENT OF THE PROBLEM: Periodontitis is a multifactorial disease caused by periopathogens and its severity is determined by the host immune response. Gingival crevicular fluid (GCF) can be used for non-invasive testing to assess the host response in periodontal treatment. Pentraxins are the classic mediators of inflammation and pentraxin-3 can be used as a marker to assess response to therapy, which was investigated in this study. PURPOSE: This study aimed to assess the effect of non-surgical periodontal therapy on GCF level of pentraxin-3 in patients with chronic periodontitis. MATERIALS AND METHOD: 25 patients with chronic periodontitis (CP) and 25 periodontally healthy controls were evaluated. Pocket probing depth, clinical attachment loss, plaque index, gingival index, and bleeding on probing were measured in both groups. GCF samples were collected using paper strips to assess the level of pentraxin-3. In the CP group, GCF samples were collected from the highest clinical attachment loss, pocket probing depth, and bone loss at baseline and six weeks after non-surgical therapy. The level of pentraxin-3 in the GCF was quantified by enzyme-linked immunosorbent assay (ELISA). Data were analyzed using SPSS version 23. RESULTS: Pentraxin-3 in GCF of CP patients before treatment (6.72±4.63 ng/mL) was higher than the control group (4.43±2.85 ng/mL). Pentraxin-3 in patients after non-surgical therapy (3.2±2.66 ng/mL) decreased significantly compared to the baseline (p= 0.04) and its level after treatment was not significantly different from the control group (p= 0.14). CONCLUSION: Pentraxin-3 in GCF of CP patients was higher than healthy controls and decreased in response to non-surgical periodontal therapy. Thus, it can be used as an inflammatory marker for detection of patients at risk of CP. However, further studies with larger samples and longer follow-ups in different populations are required to confirm our findings Shiraz University of Medical Sciences 2022-09 /pmc/articles/PMC9719594/ /pubmed/36506882 http://dx.doi.org/10.30476/DENTJODS.2021.90647.1510 Text en Copyright: © Journal of Dentistry https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License, ( http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mozaffari, Asieh
Samieifar, Mahtab
Abd Nikfarjam, Bahare
Mirzadeh, Monirsadat
Assareh, Shadi
Mirzapour, Samira Mohammad
The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title_full The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title_fullStr The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title_full_unstemmed The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title_short The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
title_sort effect of non-surgical periodontal therapy on pentraxin-3 concentration in gingival crevicular fluid of chronic periodontitis patients: a clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719594/
https://www.ncbi.nlm.nih.gov/pubmed/36506882
http://dx.doi.org/10.30476/DENTJODS.2021.90647.1510
work_keys_str_mv AT mozaffariasieh theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT samieifarmahtab theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT abdnikfarjambahare theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT mirzadehmonirsadat theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT assarehshadi theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT mirzapoursamiramohammad theeffectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT mozaffariasieh effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT samieifarmahtab effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT abdnikfarjambahare effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT mirzadehmonirsadat effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT assarehshadi effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial
AT mirzapoursamiramohammad effectofnonsurgicalperiodontaltherapyonpentraxin3concentrationingingivalcrevicularfluidofchronicperiodontitispatientsaclinicaltrial